Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.80 |
| ▸ | HPGD | P15428 | 5/20 | 0.80 |
| ▸ | AR | P10275 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | MAPT | P10636 | 3/20 | 0.72 |
| ▸ | TP53 | P04637 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | POLB | P06746 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | AGER | Q15109 | 1/20 | 0.67 |
| ▸ | KDR | P35968 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 2/20 | 0.66 |
| ▸ | MAOA | P21397 | 1/20 | 0.66 |
| ▸ | MAOB | P27338 | 1/20 | 0.66 |
| ▸ | CASP3 | P42574 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.66 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29881770 | 1.00 | ALDH1A1 (0.80) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL11316690 | 0.89 | AR (0.74) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL5717615 | 0.88 | AR (0.73) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL3210418 | 0.88 | ALDH1A1 (0.79) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL15499731 | 0.86 | ALDH1A1 (0.81) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL29677221 | 0.85 | KMT2A (0.66) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL20364004 | 0.85 | ALDH1A1 (0.77) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL9204774 | 0.85 | KMT2A (0.66) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL14883408 | 0.85 | ALDH1A1 (0.79) | ALDH1A1KDM4EHPGDARKMT2A | |
| SCHEMBL24198275 | 0.85 | ALDH1A1 (0.74) | ALDH1A1KDM4EHPGDKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113774021-B | Preparation method of biological material bracket containing mesenchymal stem cell spheres | 中国人民解放军陆军特色医学中心 | 2024-06-04 | — | — | CN | claimed |
| US-20230165965-A1 | NEW COUMARIN-POLYMER CONJUGATES AND USES THEREOF | ONYEL BIOTECH S.R.L. (IT) | 2023-06-01 | — | — | US | claimed |
| EP-4138941-A1 | NEW COUMARIN-POLYMER CONJUGATES AND USES THEREOF | Onyel Biotech S.r.l. (IT) | 2023-03-01 | — | — | EP | claimed |
| WO-2021214652-A1 | NEW COUMARIN-POLYMER CONJUGATES AND USES THEREOF | ONYEL BIOTECH S.R.L. (IT) | 2021-10-28 | — | — | WO | claimed |
| WO-2007115181-A9 | COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF | EASTMAN CHEM CO (US) | 2008-04-03 | — | — | WO | claimed |
| WO-2007115181-A2 | COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2007-10-11 | — | — | WO | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-4680227-A1 | FORMULATIONS OF DANICOPAN AND METHODS OF USE THEREOF | Alexion Pharmaceuticals, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20250188018-A1 | FORMULATIONS WITH IMPROVED STABILITY | INSPIRNA INC (US) | 2025-06-12 | — | — | US | disclosed |
| WO-2024191606-A1 | FORMULATIONS OF DANICOPAN AND METHODS OF USE THEREOF | ALEXION PHARMACEUTICALS, INC. (US) | 2024-09-19 | — | — | WO | disclosed |
| US-20240200081-A1 | NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE | Aptacure Therapeutics Limited (CN) | 2024-06-20 | — | — | US | disclosed |
| CN-113774021-B | Preparation method of biological material bracket containing mesenchymal stem cell spheres | 中国人民解放军陆军特色医学中心 | 2024-06-04 | — | — | CN | disclosed |
| EP-4316495-A1 | NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE | Aptacure Therapeutics Limited (HK) | 2024-02-07 | — | — | EP | disclosed |
| US-5510343-A | BETA-LACTAMASE INHIBITOR | HOFFMANN-LA ROCHE INC. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5419966-A | Solid support for synthesis of 3'-tailed oligonucleotides | MICROPROBE CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0547142-A4 | — | MICROPROBE CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0547142-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | EPOCH PHARMACEUTICALS, INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| WO-1992013092-A1 | METHODS OF TRANSCRIPTIONALLY MODULATING EXPRESSION OF HEMATOPOIETIC GROWTH FACTOR GENES | ONCOGENE SCIENCE, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| WO-1992012635-A1 | METHODS OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION OF VIRAL GENES AND OTHER GENES | ONCOGENE SCIENCE, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| WO-1992003464-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | MICROPROBE CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165965-A1 | NEW COUMARIN-POLYMER CONJUGATES AND USES THEREOF | CBR3, CYP3A43, CYP3A4 | ALDH1A1 263/4885KDM4E 3146/4885HPGD 281/4885 |
| US-20250188018-A1 | FORMULATIONS WITH IMPROVED STABILITY | FURIN, CEL, CTSA | ALDH1A1 2703/4885KDM4E 3519/4885HPGD 739/4885 |
| US-20240200081-A1 | NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE | SOST, FABP1, VEGFA | ALDH1A1 892/4885KDM4E 4462/4885HPGD 4553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.